Scarica l'app Stockscreener
2.32
5.94%
0.13
Dopo l'orario di chiusura:
2.32
Nkarta Inc Borsa (NKTX) Ultime notizie
If You Invested $1,000 in Nkarta, Inc. (NKTX) - Stock Titan
Nkarta (NASDAQ: NKTX) launches $100M ATM shelf via Stifel as sales agent - Stock Titan
NKTX Technical Analysis & Stock Price Forecast - Intellectia AI
Nkarta (NASDAQ:NKTX) Price Target Lowered to $12.00 at Mizuho - Defense World
NKTX PE Ratio & Valuation, Is NKTX Overvalued - Intellectia AI
Mizuho lowers Nkarta stock price target on sales ramp moderation - Investing.com
HC Wainwright Forecasts Nkarta’s Q1 Earnings (NASDAQ:NKTX) - Defense World
HC Wainwright Forecasts Nkarta's Q1 Earnings (NASDAQ:NKTX) - MarketBeat
Nkarta (NASDAQ:NKTX) Rating Lowered to Sell at Wall Street Zen - MarketBeat
TD Cowen Maintains Nkarta(NKTX.US) With Buy Rating - Moomoo
Risk Hedge: Will Nkarta Inc stock go up in YEARPortfolio Performance Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), QT Imaging Holdings (QTI) and Cardiff Oncology (CRDF) - theglobeandmail.com
Nkarta Launches $100 Million At-the-Market Stock Offering - theglobeandmail.com
Nkarta (NASDAQ:NKTX) Price Target Raised to $11.00 at Needham & Company LLC - Defense World
Nkarta, Inc. Files Form 8-K With SEC Detailing Company and Stock Information – March 25, 2026 - Minichart
NKTX (Nkarta) PB Ratio : 0.51 (As of Mar. 26, 2026) - GuruFocus
Nkarta (NASDAQ:NKTX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Stifel reiterates Nkarta stock rating on trial enrollment progress By Investing.com - Investing.com South Africa
Stifel reiterates Nkarta stock rating on trial enrollment progress - Investing.com
Nkarta launches $100M at-the-market equity program with Stifel - TradingView
Nkarta, Inc. 2025 Annual Report: Advancing Allogeneic CAR NK-Cell Therapies for Cancer and Autoimmune Diseases - Minichart
Nkarta Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aug Momentum: Should value investors consider Nkarta Inc2026 Institutional & Real-Time Volume Triggers - baoquankhu1.vn
Nkarta, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Nkarta (NASDAQ: NKTX) launches $100M at-the-market stock sale plan - Stock Titan
Nkarta Files $350 Million Mixed Shelf - MarketScreener
Nkarta (NASDAQ: NKTX) launches $100M at-the-market program via $350M shelf - Stock Titan
Nkarta (NASDAQ:NKTX) Releases Quarterly Earnings Results, Misses Expectations By $0.05 EPS - MarketBeat
Nkarta 2025 10-K: Net loss $104.1M, EPS $(1.41) - TradingView
[10-K] Nkarta, Inc. Files Annual Report - Stock Titan
Nkarta (NASDAQ: NKTX) reports 2025 loss and extends cash runway to 2029 - stocktitan.net
Nkarta reports fourth quarter and full year 2025 financial results and corporate highlights - MarketScreener
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights - GlobeNewswire
Nkarta (NKTX) to Release Earnings on Tuesday - Defense World
Trend Report: Is Nkarta Inc stock a buy or sell2026 Levels & Reliable Intraday Trade Plans - baoquankhu1.vn
Nkarta Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
NKTX Q4'25 Earnings: EPS estimate is (0.31) USD - tradingview.com
Trading Action: Will Nkarta Inc face regulatory challenges2026 Pullback Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
Street Watch: Will Nkarta Inc stock go up in YEAR2026 Volatility Report & Fast Moving Stock Watchlists - baoquankhu1.vn
Nkarta, Inc. (NASDAQ:NKTX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sectors Review: Is Nkarta Inc stock showing strong momentumMarket Movers & Verified Swing Trading Watchlists - baoquankhu1.vn
Aug Big Picture: How do insiders feel about Nkarta Inc2026 Earnings Impact & High Return Trade Guides - baoquankhu1.vn
Risk On: How sensitive is Nkarta Inc to inflation2025 Earnings Impact & Capital Efficient Trade Techniques - baoquankhu1.vn
NKTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Nkarta to Participate in March Investor Conferences - Yahoo Finance
Autoimmune cell therapy firm Nkarta lines up two March investor talks - Stock Titan
Profit Review: Does Nkarta Inc have declining or rising EPSWeekly Trade Summary & Reliable Momentum Entry Alerts - baoquankhu1.vn
NKTXNkarta, Inc. Latest Stock News & Market Updates - Stock Titan
Why analysts upgrade Nkarta Inc. stockJuly 2025 Fed Impact & Capital Protection Trade Alerts - mfd.ru
Tang Capital discloses 2.1% Nkarta (NKTX) ownership in Schedule 13G/A - Stock Titan
Death Cross: Will Nkarta Inc stock benefit from M AJuly 2025 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
How buybacks impact Nkarta Inc. stock valueShort Setup & Weekly Sector Rotation Insights - mfd.ru
Nkarta, Inc. (NASDAQ:NKTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Is Nkarta Inc. stock dividend yield sustainable2025 Biggest Moves & Safe Entry Zone Identification - mfd.ru
What is Nkarta Inc.’s book value per shareDividend Hike & Low Drawdown Trading Techniques - mfd.ru
What dividend growth rate does Nkarta Inc offer2025 Geopolitical Influence & Fast Moving Stock Watchlists - baoquankhu1.vn
Nkarta (NASDAQ:NKTX) Stock Price Down 1.5%What's Next? - MarketBeat
How sensitive is Nkarta Inc. to inflation2025 Risk Factors & Verified Momentum Stock Alerts - mfd.ru
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):